Evidence map›Paper›PMID 41186137›Full record

ArticleCPT: pharmacometrics & systems pharmacology2025

Redefining Parameter Estimation and Covariate Selection via Variational Autoencoders: One Run Is All You Need.

Jan Rohleff, Freya Bachmann, Uri Nahum, Dominic Bräm, Britta Steffens, Marc Pfister, Gilbert Koch, Johannes Schropp

Abstract read
In one paragraph

Article in CPT: pharmacometrics & systems pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Diffusion models for virtual populations and pharmacometric simulations.Journal of pharmacokinetics and pharmacodynamics · 2026
    Article
  2. Article
  3. Article
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Jan RohleffDepartment of Mathematics and Statistics, University of Konstanz, Konstanz, Germany.ORCID 0009-0003-8472-4320
Freya BachmannDepartment of Mathematics and Statistics, University of Konstanz, Konstanz, Germany.ORCID 0000-0002-3246-4120
Uri NahumPediatric Pharmacology and Pharmacometrics, University Children's Hospital Basel (UKBB), University of Basel, Basel, Switzerland.ORCID 0000-0001-6186-1830
Dominic BrämPediatric Pharmacology and Pharmacometrics, University Children's Hospital Basel (UKBB), University of Basel, Basel, Switzerland.ORCID 0000-0001-9094-8361
Britta SteffensPediatric Pharmacology and Pharmacometrics, University Children's Hospital Basel (UKBB), University of Basel, Basel, Switzerland.ORCID 0009-0002-2259-4180
Marc PfisterPediatric Pharmacology and Pharmacometrics, University Children's Hospital Basel (UKBB), University of Basel, Basel, Switzerland.ORCID 0000-0003-2597-1228
Gilbert KochPediatric Pharmacology and Pharmacometrics, University Children's Hospital Basel (UKBB), University of Basel, Basel, Switzerland.ORCID 0000-0002-9386-0506
Johannes SchroppDepartment of Mathematics and Statistics, University of Konstanz, Konstanz, Germany.

Funding

National Science Foundation
6 · The paper itself

Abstract

Generative Artificial Intelligence (AI) frameworks, such as Variational Autoencoders (VAEs), have proven powerful in learning structured representations from complex, high-dimensional data. In pharmacometrics (PMX), nonlinear mixed effects (NLME) modeling is widely used to capture inter-individual variability and link covariates to characterize parameters with the goal of informing key decisions in drug research and development. This research combines the strengths of both approaches by introducing a VAE framework specifically designed for NLME modeling. The proposed method integrates the flexibility of generative AI with the interpretability and robustness of mechanism-based PMX modeling. To advance covariate selection in PMX, we replace the Evidence Lower Bound objective in VAEs with an objective function based on the corrected Bayesian information criterion. This enables the simultaneous evaluation of all potential covariate-parameter combinations, thereby allowing for automated and joint estimation of population parameters and covariate selection within a single run. Manual selection and repeated model fitting across covariate combinations are no longer required. We demonstrate the effectiveness of this combined AI-PMX approach with two representative cases. As the first generative AI-based optimization method for NLME modeling, the VAE achieves high-quality results in a single run, outperforming traditional stepwise procedures in terms of efficiency. As such, the presented approach facilitates automated model development, advancing PMX and its applications in model-informed drug development.

Indexed as

Artificial IntelligenceAutoencoderBayes TheoremDrug DevelopmentHumansNonlinear DynamicsBayesian inferencecovariate selectiondata‐driven modelinggenerative artificial intelligence (AI)machine learningnonlinear mixed effects modelingparameter estimationvariational autoencoder

Identifiers

PMID41186137
PMCPMC12706427

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.